SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $229,000 | -4.2% | 15,314 | -22.4% | 0.00% | – |
| Q1 2016 | $239,000 | +100.8% | 19,727 | +161.8% | 0.00% | – |
| Q4 2015 | $119,000 | -25.2% | 7,534 | -27.3% | 0.00% | – |
| Q3 2015 | $159,000 | -41.3% | 10,361 | -6.6% | 0.00% | – |
| Q2 2015 | $271,000 | +25.5% | 11,094 | +19.7% | 0.00% | – |
| Q1 2015 | $216,000 | -26.0% | 9,271 | -20.5% | 0.00% | – |
| Q4 2014 | $292,000 | -17.0% | 11,656 | +3.1% | 0.00% | – |
| Q3 2014 | $352,000 | +20.5% | 11,304 | +0.3% | 0.00% | – |
| Q2 2014 | $292,000 | -24.9% | 11,270 | -32.4% | 0.00% | – |
| Q1 2014 | $389,000 | -8.3% | 16,681 | -0.3% | 0.00% | – |
| Q4 2013 | $424,000 | +1414.3% | 16,735 | +1103.1% | 0.00% | – |
| Q3 2013 | $28,000 | +3.7% | 1,391 | +7.7% | 0.00% | – |
| Q2 2013 | $27,000 | – | 1,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |